Carlos Matute Almau-rekin lankidetzan egindako argitalpenak (50)

2024

  1. Autoimmune inflammation triggers aberrant astrocytic calcium signaling to impair synaptic plasticity

    Brain, Behavior, and Immunity, Vol. 121, pp. 192-210

2023

  1. Endocannabinoid signaling in brain diseases: Emerging relevance of glial cells

    GLIA, Vol. 71, Núm. 1, pp. 103-126

  2. Hepatic levels of S-adenosylmethionine regulate the adaptive response to fasting

    Cell Metabolism, Vol. 35, Núm. 8, pp. 1373-1389.e8

  3. Spatial organization of neuron-astrocyte interactions in the somatosensory cortex

    Cerebral cortex (New York, N.Y. : 1991), Vol. 33, Núm. 8, pp. 4498-4511

  4. The endocannabinoid system and autoimmune demyelination: A focus on multiple sclerosis

    Neurobiology and Physiology of the Endocannabinoid System (Elsevier), pp. 229-240

  5. Therapeutic effect of α7 nicotinic receptor activation after ischemic stroke in rats

    Journal of Cerebral Blood Flow and Metabolism, Vol. 43, Núm. 8, pp. 1301-1316

2022

  1. Cannabinoid CB1 receptor expression in oligodendrocyte progenitors of the hippocampus revealed by the NG2-EYFP-knockin mouse

    Frontiers in Neuroanatomy, Vol. 16

  2. Cannabinoid CB1 receptor gene inactivation in oligodendrocyte precursors disrupts oligodendrogenesis and myelination in mice

    Cell Death and Disease, Vol. 13, Núm. 7

  3. Characterization of molecular biomarkers in cerebrospinal fluid and serum of E46K-SNCA mutation carriers

    Parkinsonism and Related Disorders, Vol. 96, pp. 29-35

2021

  1. Astrocytic atrophy as a pathological feature of Parkinson’s disease with LRRK2 mutation

    npj Parkinson's Disease, Vol. 7, Núm. 1

  2. Effects of platelet-rich plasma on cellular populations of the central nervous system: The influence of donor age

    International Journal of Molecular Sciences, Vol. 22, Núm. 4, pp. 1-20

  3. Fit-for-purpose based testing and validation of antibodies to amino- and carboxy-terminal domains of cannabinoid receptor 1

    Histochemistry and Cell Biology, Vol. 156, Núm. 5, pp. 479-502

  4. Δ9-Tetrahydrocannabinol promotes functional remyelination in the mouse brain

    British Journal of Pharmacology, Vol. 178, Núm. 20, pp. 4176-4192

  5. Δ9-Tetrahydrocannabinol promotes oligodendrocyte development and CNS myelination in vivo

    GLIA, Vol. 69, Núm. 3, pp. 532-545

2020

  1. Gene expression analysis of astrocyte and microglia endocannabinoid signaling during autoimmune demyelination

    Biomolecules, Vol. 10, Núm. 9, pp. 1-19

  2. P2x7 receptors control demyelination and inflammation in the cuprizone model

    Brain, Behavior, and Immunity - Health, Vol. 4

2018

  1. Centenary of the death of Dr. Nicolás achúcarro lund and the fiftieth anniversary of the creation of the nicolás achúcarro neuropsychiatric institute (Hospital Zamudio) (summary)

    Gaceta Medica de Bilbao

  2. Deregulation of the endocannabinoid system and therapeutic potential of ABHD6 blockade in the cuprizone model of demyelination

    Biochemical Pharmacology, Vol. 157, pp. 189-201

  3. Inhibition of Casein Kinase 2 Protects Oligodendrocytes From Excitotoxicity by Attenuating JNK/p53 Signaling Cascade

    Frontiers in Molecular Neuroscience, Vol. 11

  4. Re-examining the potential of targeting ABHD6 in multiple sclerosis: Efficacy of systemic and peripherally restricted inhibitors in experimental autoimmune encephalomyelitis

    Neuropharmacology, Vol. 141, pp. 181-191